Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Critical Care Cardiology
•
Hospital Medicine
What are your preferred induction agents for RSI in patients with severe aortic stenosis and reduced LVEF?
Related Questions
When do you usually introduce conversations regarding tracheostomy placement in patients with refractory status epilepticus, or other conditions where one may anticipate delayed awakening?
What would be your approach to percutaneous intervention for acute plaque rupture and cardiogenic shock for a patient with cirrhosis and severe thrombocytopenia?
What has been your stepwise approach to oxygenation, including when to consider the use of inhaled nitric oxide or epoprostenol, in refractory hypoxemia due to cardiogenic pulmonary edema in patients who are otherwise not ECMO candidates?
What is your approach when a patient has concomitant acute decompensated heart failure and rapid atrial fibrillation?
Is there any evidence to support further uptitration of dobutamine beyond 5mcg/kg/min for patients with advanced HF and/or cardiogenic shock, or should further investigation into potential MCS be considered at that point?
What is your approach to checking preoperative cardiac biomarkers such as troponin and BNP?
How do you consider and approach transition to hospice in a patient with HFrEF who does not appear to tolerate GDMT?
What are the best techniques to reduce POCUS artifact and increase the diagnostic accuracy of lung ultrasound?
How do you decide between opting for semi-elective outpatient versus inpatient TAVR for patients with severe critical AS?
How do you approach caring for patients admitted with decompensated CHF, but who also exhibit hypotension and do not have overt signs of hypervolemia on exam?
